Search the Newsreel

GE HealthCare taps retiring AT&T CFO for board of directors

GE HealthCare has announced the appointment of AT&T's outgoing chief financial officer, Pascal Desroches, to its board of directors, effective January 4, 2027. Desroches, who plans to retire from AT&T at the end of the year, brings extensive financial leadership experience from his roles …

GE HealthCare Technologies boosts dividend by 14.3% to $0.04 a share

* GE HealthCare Technologies (GEHC [https://seekingalpha.com/symbol/GEHC]) declares $0.04/share quarterly dividend [https://seekingalpha.com/pr/20660671-ge-healthcare-announces-cash-dividend-increase-for-third-quarter-of-2026], 14.3% increase from prior dividend of $0.035. * Forward yield [https://seekingalpha.com/symbol/GEHC/dividends/yield?source=news_bullet] 0.24% * Payable Nov. 13; for shareholders of record Oct. 23; ex-div Oct. 23. * The company raised its quarterly dividend by …

GE HealthCare names AT&T CFO Pascal Desroches to board effective Jan. 4, 2027

GE HealthCare has announced the appointment of AT&T CFO Pascal Desroches to its board of directors, effective January 4, 2027. Desroches, who has been AT&T's CFO since 2021, plans to retire from the telecom group on December 31, 2026. His career includes previous roles …

GE Healthcare Technologies Increases Quarterly Dividend to $0.04 a Share, Payable Nov. 13 to Holders of Record Oct. 23

GE Healthcare Technologies has announced an increase in its quarterly dividend to $0.04 per share. This dividend will be payable on November 13 to shareholders of record as of October 23. This news comes amidst other recent announcements, including a new board appointment and …

GE Healthcare Technologies Inc. Declares Cash Dividend for the Third Quarter of 2026, Payable on November 13, 2026

GE HealthCare Technologies Inc. announced a cash dividend of $0.04 per share of Common Stock for the third quarter of 2026, marking a 14% increase from the previous quarter. The dividend is scheduled to be paid on November 13, 2026, to shareholders of record …

GE HealthCare announces cash dividend increase for third quarter of 2026

CHICAGO, September 22, 2026--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.04 per share of Common Stock for the third quarter of 2026, an increase of 14% from the previous quarter. The dividend will …

Press Release: GE HealthCare Announces Cash Dividend Increase for Third Quarter of 2026

GE HealthCare (NASDAQ: GEHC) announced a cash dividend increase to $0.04 per share for the third quarter of 2026, marking a 33% rise from the previous quarter's dividend. The dividend is payable on November 15, 2026, to shareholders of record as of October 25, …

GE HealthCare Appoints Pascal Desroches to Board Committees

GE HealthCare Technologies Inc. announced the appointment of Pascal Desroches to its Board of Directors, effective January 4, 2027. Desroches will serve on the Audit Committee and the Talent, Culture, and Compensation Committee. This appointment is part of GE HealthCare's focus on strong financial …

GE Healthcare Technologies Inc. Announces Appointment of Pascal Desroches to Board of Directors, Effective January 4, 2027

GE HealthCare Technologies Inc. has announced the appointment of Pascal Desroches, the Senior Executive Vice President and CFO of AT&T, to its Board of Directors, effective January 4, 2027. Desroches brings over 30 years of leadership experience in finance, governance, and large-scale technology and …

AT&T CFO to join GE HealthCare (Nasdaq: GEHC) board in 2027

GE HealthCare announced the appointment of Pascal Desroches, current Senior Executive Vice President and CFO of AT&T, to its Board of Directors, effective January 4, 2027. Desroches, who plans to retire from AT&T on December 31, 2026, will also join the Board’s Audit Committee …

GE HealthCare appoints veteran finance executive Pascal Desroches to Board of Directors

CHICAGO, September 22, 2026--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the appointment of Pascal Desroches, Senior Executive Vice President and Chief Financial Officer (CFO) of AT&T (NYSE: T), a Fortune 50 company, to its Board of Directors, effective January 4, 2027. Mr. Desroches brings …

GEHC Could Be Set For A Turnaround — Needham Sees 44% Upside For GE Healthcare After Nearly 21% YTD Slide

Needham has initiated coverage on GE Healthcare (GEHC) with a 'Buy' rating and a $93 price target, signaling a potential 44% upside after the stock's year-to-date decline. The firm anticipates mid-single-digit revenue growth and high-single-digit EPS growth for GEHC over the next year, expecting …

Needham initiates GE HealthCare stock coverage with buy rating By Investing.com

Needham has initiated coverage on GE HealthCare Technologies Inc. (NASDAQ: GEHC) with a buy rating and a price target of $93.00, citing significant upside potential from its current trading price of $64.81. The firm's analysis suggests that the stock largely prices in a bear …

Needham Initiates GE Healthcare Technologies at Buy With $93 Price Target

Needham has initiated coverage on GE Healthcare Technologies with a "Buy" rating and a price target of $93. The article highlights that GE HealthCare Technologies is a healthcare solutions provider focusing on medical technology, pharmaceutical diagnostics, and AI-enabled solutions across several segments including Imaging …

Is GE HealthCare Technologies (GEHC) Undervalued On Its CareIntellect AI Launch?

GE HealthCare Technologies (GEHC) just launched CareIntellect for Operations, an AI SaaS tool that forecasts hospital capacity constraints up to 72 hours ahead and suggests actions, giving investors another data point on its software push. Despite the AI push, GE HealthCare Technologies shares have …

GE HealthCare stock steadies as Sofie Biosciences deal talks and analyst targets frame valuation

GE HealthCare's stock is currently trading around USD 64.13, with analysts projecting a 21% upside to an average target of USD 77.73. The company is reportedly in advanced talks to acquire Sofie Biosciences for approximately USD 1 billion, aiming to expand its pharmaceutical diagnostics …

At US$64.13, Is GE HealthCare Technologies Inc. (NASDAQ:GEHC) Worth Looking At Closely?

This article analyzes GE HealthCare Technologies Inc. (NASDAQ:GEHC) stock, currently priced at US$64.13, to determine if it is an attractive investment. It likely delves into valuation metrics, financial performance, and market sentiment to assess its potential. The analysis will help investors decide if the …

GE HealthCare stock edges lower as Sofie Biosciences deal talks draw attention

GE HealthCare stock saw a slight decline amid reports of advanced talks to acquire Sofie Biosciences for approximately $1 billion. This potential acquisition would vertically integrate GE HealthCare's imaging business with diagnostic radiopharmaceutical supplies, enhancing its product offerings. Despite this, and recent quarterly results …

Notable healthcare headlines for the week: Novo Nordisk, GE HealthCare, and Eli Lilly in focus

Wall Street's major market averages finished mixed as Treasury yields rebounded, rekindling concerns about a deteriorating macroeconomic backdrop. The S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#source=url_first_level%3Amarket-news%7Csection%3Amarket-pulse%7Csection_asset%3Afull_story%7Cbutton%3Abody_link]) inched 0.2% higher and the Dow inched 95 points lower, while the Nasdaq added 0.7%. The S&P 500 Health Care Index …

Key deals this week: SPGI, PSO, GEHC, and more

[word m and a made with wood building blocks, stock image] Maksim Labkouski/iStock via Getty Images Here's a list of key deals reported across sectors this week: * S&P Global (SPGI [https://seekingalpha.com/symbol/SPGI]) has entered into an agreement to acquire leading on-chain security assessments platform …

GE HealthCare Technologies (GEHC) Stock Forecast and Price Target 2026

GE HealthCare Technologies (GEHC) currently holds a "Hold" consensus rating from 21 Wall Street analysts, with an average 12-month price target of $77.73, representing a potential upside of 19.93% from its current price of $64.81. Analysts issued 11 hold ratings and 10 buy ratings. …

Securities Fraud Investigation Into GE HealthCare

The Law Offices of Frank R. Cruz is continuing its securities fraud investigation into GE HealthCare Technologies Inc. (GEHC) on behalf of investors who lost money. The investigation stems from GE HealthCare's Q1 2026 financial results, which included lowered EPS guidance and disclosures about …

GE HealthCare (GEHC) CFO files ownership form with zero reported shares

GE HealthCare's Chief Financial Officer, William K. Grogan, has filed an initial statement of beneficial ownership (Form 3) with the SEC, reporting no current holdings or transactions of GEHC securities. This filing indicates his new status as an insider with no initial stock ownership. …

GE HealthCare CFO Grogan William K Granted 31,877 Derivative Securities and 75,096 Shares

GE HealthCare Technologies Inc. has awarded its CFO, Grogan William K, 75,096 shares and 31,877 derivative securities at no cost. These transactions, recorded on September 14, 2026, represent 100% of his resulting holdings in both share and derivative categories. The awards provide transparency into …

GE HealthCare Technologies Inc. stock rises Thursday, outperforms market

GE HealthCare Technologies Inc. (GEHC) stock increased by 1.50% on Thursday, closing at $64.45. This performance outperformed the broader market, with the S&P 500 Index rising 1.14% and the Dow Jones Industrial Average gaining 0.61%. The rise ended a two-day losing streak for the …

GE HealthCare stock maintained at Buy by BTIG on imaging tech

BTIG reiterated a Buy rating and $79.00 price target for GE HealthCare (NASDAQ:GEHC) due to positive feedback on its new Photonova Spectra photon-counting CT system. The company received FDA clearance in March and CE Mark approval in August, and its system is praised for …

GE HealthCare (GEHC) Reportedly Eyes $1B Sofie Deal. What Would Ownership Add?

GE HealthCare Technologies Inc. (NASDAQ:GEHC) is reportedly discussing a possible $1 billion acquisition of Sofie Biosciences. Reuters reported the talks on September 13, citing the Financial Times, which attributed them to people familiar with the matter. Reuters could not independently verify the report, and …

GE HealthCare CFO William K. Grogan Awarded RSUs and Stock Options on September 14, 2026

GE HealthCare CFO William K. Grogan was awarded restricted stock units (RSUs) and employee stock options on September 14, 2026, as detailed in an SEC Form 4 filing. The awards include 62,256 RSUs vesting in two tranches, 12,840 RSUs vesting in three installments, and …

GEHC or SYK: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Products sector might want to consider either GE HealthCare Technologies (GEHC) or Stryker (SYK). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. …

GEHC Launches CareIntellect AI Tool to Optimize Hospital Operations

GE HealthCare (GEHC) has introduced CareIntellect for Operations, an AI-powered SaaS application designed to help health systems predict and manage operational bottlenecks up to 72 hours in advance. This tool, running on AWS, combines patient and operational data with proprietary AI models to provide …

GE HealthCare launches AI tool to forecast hospital capacity By Investing.com

GE HealthCare has launched CareIntellect for Operations, an AI-enabled software application designed to predict hospital capacity constraints up to 72 hours in advance. This tool analyzes various operational and patient data points using two proprietary AI models to optimize capacity and throughput. The Queen's …

GE Healthcare Technologies Launches CareIntellect Software to Streamline Hospital Operations

GE HealthCare Announces CareIntellect for Operations, Helping Health Systems Optimize Resources and Expand Access to Care

GE HealthCare has launched CareIntellect for Operations, an AI-enabled SaaS application designed to help health systems predict and manage capacity constraints up to 72 hours in advance. This solution leverages proprietary AI models and two decades of hospital operations expertise to provide actionable guidance …